The commercial success of new pharma products is heavily reliant on a smart payer strategy that takes multiple variables into account, from understanding different key payer stakeholders to developing strategies that effectively communicate a product’s value and align on its positioning. In today’s pharmaceutical environment, a generalized, one-size-fits-all approach isn’t sufficient for optimizing a product’s revenue or patients’ access to it.

Instead, manufacturers need a detailed strategy that integrates with their overall brand strategy. This is our focus at Two Labs Market Access.

Our Pharmaceutical Market Access Services

Our Market Access team has executed over 250 market access engagement over the past 7 years, focusing on the following areas:

US and Global Pricing Strategy

To maximize your revenue, it’s vital that you develop proper modeling that takes payers, physicians and patients into consideration.

US and Global Market Access Landscape

Gaining a thorough understanding of the market, as well as future projections, is critical for sound decision making.

US and Global Payer Panel and Advisory Board

To understand the pricing and market access potential for new treatments, clients need to hear from KOLs and government policy makers.

Payer Segmentation, Contracting and Plan by Plan Analysis

In today’s competitive landscape, a one-size-fits-all approach to your market access strategy is not enough.

Payer Value Message Development and Testing

The right payer strategy takes a holistic approach, one that considers the unique business objectives of various payers to develop strategies that seek to maximize script volume and profitability.

Loss of Exclusivity

Just as with launching a new product, managing a product’s loss of exclusivity (LOE) requires strategic planning and oversight.

Patient Out of Pocket Analysis

It’s imperative manufacturers have a thorough understanding of out of pocket (OOP) costs and the reimbursement support options available to them.

Let’s Get Started.

Go to Top